Bristol-Myers bipolar therapy delays relapse
Pharmaceutical Business Review - Dec 8, 2006… with Bristol-Myers Squibb and Otsuka Pharmaceuticals’ antipsychotic Abilify significantly delayed time to relapse in adults with bipolar disorder according to …